IRLA Kronos AI forecast
A 30-trading-day price forecast for IRulya Therapeutics Inc. (IRLA) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts IRulya Therapeutics Inc. at $26.75 on 2026-12-08, −17.6% from the last close of $32.47 on 2026-10-27. Eight out of ten sampled paths end between $24.89 and $30.05, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of IRLA
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $35.15 | $30.65 | $38.69 |
| 2026-11-10 | $32.33 | $30.58 | $34.51 |
| 2026-11-17 | $28.50 | $26.86 | $30.84 |
| 2026-11-24 | $26.94 | $25.25 | $31.45 |
| 2026-12-01 | $27.15 | $25.82 | $29.42 |
| 2026-12-08 | $26.75 | $24.89 | $30.05 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for IRLA?
- Kronos AI's median forecast for IRLA is $26.75 in 30 trading days, −17.6% from the last close, with a 10–90% range of $24.89 to $30.05.
- Is the IRLA Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.